- Quantum Computing Inc. (QUBT, Financial) announces CEO Dr. William McGann's retirement in May 2025.
- Dr. Yuping Huang appointed as Interim CEO, initiating a search for a permanent successor.
- Dr. McGann led significant company advancements, including the Dirac-3 quantum optimization machine.
Quantum Computing Inc. (QUBT), headquartered in Hoboken, NJ, has announced that its current Chief Executive Officer and President, Dr. William McGann, will retire effective May 12, 2025. Dr. McGann, who joined QCi's board in September 2021 and became CEO in February 2024, has been instrumental in advancing key initiatives for the company, including the launch of the Dirac-3 quantum optimization machine and the establishment of the company's chip foundry.
The Board of Directors has designated Dr. Yuping Huang as the Interim CEO and President. Dr. Huang, who currently serves as Chairman of the Board and Chief Quantum Officer, brings over 20 years of expertise in quantum and optics technology to his new role. His prior achievements include the founding of QPhoton Inc., which was acquired by QCi in June 2022. Additionally, Dr. Huang is recognized for his management of quantum research projects valued at over $40 million, funded by prestigious agencies such as the Department of Defense and NASA.
Dr. McGann expressed his gratitude to QCi's employees, shareholders, and partners, acknowledging their role in progressing the company's mission to deliver quantum technologies that address real-world challenges. He remarked, "It has been an honor to lead QCi alongside such a dedicated team. Together, we've made strides in advancing the Company's mission and delivering quantum technologies that address real-world problems today."
Quantum Computing Inc. (QUBT, Financial) is noted for its innovative approach to photonics and quantum optics technology, providing accessible quantum machines designed for room temperature and low power use. As QCi transitions to new leadership, Dr. Huang aims to focus on expanding government contracts, leveraging his substantial experience in securing research funding.